{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:30:19Z","timestamp":1790638219334,"version":"4.1.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Hum. Neurosci."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Benzodiazepines (BZDs) and Non-BZDs (NBZDs) have been widely used for patients with chronic insomnia. Long-term uses of BZDs may cause cognitive impairment and increase the risk for dementia in older patients. NBZD as an agonist of the GABA<jats:sub>A<\/jats:sub> receptor complex includes eszopiclone, zopiclone, zolpidem, and zaleplon, also collectively known as Z drugs. However, evaluations for an association between cognitive impairment and Z drug use have been limitedly performed. This study aimed to investigate the association between the risk of cognitive decline and exposure to Z drugs in middle-aged and older patients with chronic insomnia.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Investigations were performed on patients with chronic insomnia who visited the outpatient Department of Neurology, Beijing Friendship Hospital, and were assessed for the global cognitive function (MoCA) and memory (AVLT), executive function (TMT-B), visuospatial ability (CDT), verbal function (BNT-30), and attention (DST). Multiple regression analysis was conducted to determine the independent factors of cognition and evaluated the effect of Z drug use (zolpidem and zopiclone) on cognition.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 120 subjects were identified. In our analysis, BZD exposure density (<jats:italic>P<\/jats:italic> = 0.025, OR = 1.43, 95% CI, 1.25\u20131.86) was an independent risk factor of cognitive impairment in middle-aged and older patients with chronic insomnia. Neither Z drug use (<jats:italic>P<\/jats:italic> = 0.103) nor Z drug exposure density (<jats:italic>P<\/jats:italic> = 0.765) correlated with global cognitive function. Moreover, there was a positive association between Z drug use and attention [(<jats:italic>P<\/jats:italic> = 0.002, OR = 0.42, 95% CI, 0.24\u20130.73)]. Additionally, income level (<jats:italic>P<\/jats:italic> = 0.001, OR = 0.23, 95% CI, 0.10\u20130.53), severity of insomnia (<jats:italic>P<\/jats:italic> = 0.019, OR = 1.20, 95% CI, 1.03\u20131.40) and age (<jats:italic>P<\/jats:italic> = 0.044, OR = 1.07, 95% CI, 1.00\u20131.14) were also independent factors of global cognitive function.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> BZD exposure density was an independent risk factor of cognitive impairment in middle-aged and older patients with chronic insomnia, but no correlation was found between Z drug use and cognitive impairment. Moreover, the use of Z drugs seemed to be associated with protection for attention. The use for prescription of BZDs, in this case, should be avoided or limited to low doses. Due to the addiction and tolerance, Z drugs should also be prescribed with great caution in middle-aged and elderly patients.<\/jats:p>","DOI":"10.3389\/fnhum.2021.775144","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T13:25:24Z","timestamp":1639056324000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Association Between Z Drugs Use and Risk of Cognitive Impairment in Middle-Aged and Older Patients With Chronic Insomnia"],"prefix":"10.3389","volume":"15","author":[{"given":"Fang","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jie","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1124\/pr.117.014381","article-title":"Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery.","volume":"70","author":"Atkin","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"780","DOI":"10.4103\/2249-4863.201153","article-title":"Prevalence of chronic insomnia in adult patients and its correlation with medical comorbidities.","volume":"5","author":"Bhaskar","year":"2016","journal-title":"J. Family Med. Prim. Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40263-016-0404-x","article-title":"Benzodiazepine use and risk of developing Alzheimer\u2019s disease: a case-control study based on swiss claims data.","volume":"31","author":"Bietry","year":"2017","journal-title":"CNS Drugs"},{"key":"B4","doi-asserted-by":"publisher","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study.","volume":"349","author":"Billioti","year":"2014","journal-title":"BMJ"},{"key":"B5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/0898264318795567","article-title":"Treatment of sleep disturbance may reduce the risk of future probable Alzheimer\u2019s disease.","volume":"31","author":"Burke","year":"2019","journal-title":"J. Aging Health"},{"key":"B6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.sleep.2018.09.001","article-title":"Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications.","volume":"52","author":"Burke","year":"2018","journal-title":"Sleep Med."},{"key":"B7","first-page":"13","article-title":"Screening of dementia in Chinese elderly adults by the clock drawing test and the time and change test.","volume":"11","author":"Chan","year":"2005","journal-title":"Hong Kong Med. J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/psyg.12239","article-title":"Association between high cumulative dose of benzodiazepine in Chinese patients and risk of dementia: a preliminary retrospective case-control study.","volume":"17","author":"Chan","year":"2017","journal-title":"Psychogeriatrics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1111\/jgs.15018","article-title":"The association between the use of Zolpidem and the risk of Alzheimer\u2019s disease among older people.","volume":"65","author":"Cheng","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.eurpsy.2011.11.003","article-title":"Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal.","volume":"28","author":"Dell\u2019Osso","year":"2013","journal-title":"Eur. Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2019.08.008","article-title":"Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the multidomain Alzheimer preventive trial cohort.","volume":"84","author":"Desmidt","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"B12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jamda.2019.08.006","article-title":"Cognitive outcomes of long-term benzodiazepine and related drug (BDZR) use in people living with mild to moderate Alzheimer\u2019s disease: results from NILVAD.","volume":"21","author":"Dyer","year":"2020","journal-title":"J. Am Med. Dir. Assoc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12877-019-1280-2","article-title":"Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study.","volume":"19","author":"Grossi","year":"2019","journal-title":"BMC Geriatr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.2466\/pms.97.8.1209-1218","article-title":"Digit Span as a measure of everyday attention: a study of ecological validity.","volume":"97","author":"Groth-Marnat","year":"2003","journal-title":"Percept. Mot. Skills"},{"key":"B15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13181-013-0292-0","article-title":"The clinical and forensic toxicology of Z-drugs.","volume":"9","author":"Gunja","year":"2013","journal-title":"J. Med. Toxicol."},{"key":"B16","first-page":"53","article-title":"Sleep and attention in Alzheimer\u2019s disease.","volume":"92","author":"Hennawy","year":"2019","journal-title":"Yale J. Biol. Med."},{"key":"B17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s40264-015-0319-3","article-title":"Benzodiazepine use and risk of developing Alzheimer\u2019s disease or vascular dementia: a case-control analysis.","volume":"38","author":"Imfeld","year":"2015","journal-title":"Drug Saf."},{"key":"B18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.euroneuro.2012.05.003","article-title":"Benzodiazepine-induced spatial learning deficits in rats are regulated by the degree of modulation of alpha1 GABA(A) receptors.","volume":"23","author":"Joksimovic","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbi.2017.04.007","article-title":"Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-beta oligomers in mice.","volume":"64","author":"Kincheski","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/wps.20674","article-title":"The assessment and management of insomnia: an update.","volume":"18","author":"Krystal","year":"2019","journal-title":"World Psychiatr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e204413","DOI":"10.1371\/journal.pone.0204413","article-title":"Use of sedative-hypnotics and the risk of Alzheimer\u2019s dementia: a retrospective cohort study.","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3233\/JAD-160119","article-title":"Mini-mental state examination in elderly Chinese: a population-based normative study.","volume":"53","author":"Li","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"B23","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care.","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"9402","DOI":"10.12659\/MSM.920900","article-title":"Validity and reliability of the international physical activity questionnaire in chinese hemodialysis patients: a multicenter study in China.","volume":"25","author":"Lou","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"B25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/0891988711422528","article-title":"Montreal cognitive assessment in detecting cognitive impairment in Chinese elderly individuals: a population-based study.","volume":"24","author":"Lu","year":"2011","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.smrv.2011.08.001","article-title":"Does abnormal non-rapid eye movement sleep impair declarative memory consolidation?: disturbed thalamic functions in sleep and memory processing.","volume":"16","author":"Lu","year":"2012","journal-title":"Sleep Med. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s12031-018-1246-4","article-title":"The alpha5-Containing GABAA receptors-a brief summary.","volume":"67","author":"Mohamad","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"B28","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","article-title":"The glymphatic pathway in neurological disorders.","volume":"17","author":"Rasmussen","year":"2018","journal-title":"Lancet Neurol."},{"key":"B29","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/jsr.12594","article-title":"European guideline for the diagnosis and treatment of insomnia.","volume":"26","author":"Riemann","year":"2017","journal-title":"J. Sleep Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults.","volume":"4","author":"Schutte-Rodin","year":"2008","journal-title":"J. Clin. Sleep. Med."},{"key":"B31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","article-title":"Benzodiazepine, psychotropic medication, and dementia: a population-based cohort study.","volume":"12","author":"Shash","year":"2016","journal-title":"Alzheimers Dement."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e809","DOI":"10.1097\/md.0000000000000809","article-title":"An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study.","volume":"94","author":"Shih","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"B33","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","article-title":"Cognitive reserve in ageing and Alzheimer\u2019s disease.","volume":"11","author":"Stern","year":"2012","journal-title":"Lancet Neurol."},{"key":"B34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/sleep\/30.2.213","article-title":"Comorbidity of chronic insomnia with medical problems.","volume":"30","author":"Taylor","year":"2007","journal-title":"Sleep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0887-6177(03)00039-8","article-title":"Trail making test A and B: normative data stratified by age and education.","volume":"19","author":"Tombaugh","year":"2004","journal-title":"Arch. Clin. Neuropsychol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2174\/138920011796504473","article-title":"Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems.","volume":"12","author":"Trifiro","year":"2011","journal-title":"Curr. Drug Metab."},{"key":"B37","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0028-3932(89)90186-3","article-title":"Boston naming test in Alzheimer\u2019s disease.","volume":"27","author":"Williams","year":"1989","journal-title":"Neuropsychologia"},{"key":"B38","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment \u2013 beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment.","volume":"256","author":"Winblad","year":"2004","journal-title":"J. Intern. Med."},{"key":"B39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain.","volume":"342","author":"Xie","year":"2013","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.anr.2016.09.002","article-title":"Influencing factors for sleep quality among shift-working nurses: a cross-sectional study in china using 3-factor Pittsburgh sleep quality index.","volume":"10","author":"Zhang","year":"2016","journal-title":"Asian Nurs. Res. (Korean Soc. Nurs. Sci.)."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e51157","DOI":"10.1371\/journal.pone.0051157","article-title":"Short-term delayed recall of auditory verbal learning test is equivalent to long-term delayed recall for identifying amnestic mild cognitive impairment.","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"}],"container-title":["Frontiers in Human Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnhum.2021.775144\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T13:25:38Z","timestamp":1639056338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnhum.2021.775144\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":41,"alternative-id":["10.3389\/fnhum.2021.775144"],"URL":"https:\/\/doi.org\/10.3389\/fnhum.2021.775144","relation":{},"ISSN":["1662-5161"],"issn-type":[{"value":"1662-5161","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,9]]},"article-number":"775144"}}